NORWEGIAN PHARMA AS
Omega-3 products of highest quality | Norwegian Pharma,Omega-3 products of highest quality | Norwegian Pharma
Norwegian Omega-3 has been created around a simple objective: To make the purest multipurpose omega-3 possible.,Norwegian Omega-3 has been created around a simple objective: To make the purest multipurpose omega-3 possible. We wanted to make it easy for those who simply want the best.
Links
Organization
- CEO
- AH
Arve Høgemark1972
- Chairman of the board
- FH
Fredrik Haven1987
- Years since formation
- 16 years
- since Mar 10, 2009
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 100
- 1 share class
- Total number of shareholders
- 5
- 3 companies, 2 persons
Financials
- Total operating income 2024
- 10,960,739
- NOK
- Annual total result 2024
- 1,252,154
- NOK
- Total equity 2024
- 3,309,444
- NOK
Last update: Sep 9, 2025
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
AH 1972 | Managing Director/CEO | 20 % directly |
Board
| Name | Role | Shares |
|---|---|---|
FH 1987 | Chairman | 20 % directly |
OF | Board Member | 20 % indirectly |
AH 1972 | Board Member | 20 % directly |
PM | Board Member | 20 % indirectly |
SN 1970 | Board Member | 14 % indirectly |
Others
| Name | Role | Shares |
|---|---|---|
| Auditor | - | |
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
FH 1987 | Chairman | 20 % directly |
AH 1972 | Managing Director/CEO, Board Member | 20 % directly |
OF | Board Member | 20 % indirectly |
PM | Board Member | 20 % indirectly |
SN 1970 | Board Member | 14 % indirectly |
ON 2005 | - | 3 % indirectly |
Last update: Dec 6, 2024
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 20 | 20 % | |
| Ordinary shares | 20 | 20 % | |
| Ordinary shares | 20 | 20 % | |
AH 1972 | Ordinary shares | 20 | 20 % |
FH 1987 | Ordinary shares | 20 | 20 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2024 | 2023 | 2022 |
|---|---|---|---|
Total operating income | 10,960,739 | 10,039,483 | 10,862,203 |
Annual Total Result | 1,252,154 | 1,237,250 | 1,573,694 |
Total assets | 4,384,947 | 6,011,779 | 6,879,881 |
Total liabilities | 1,075,503 | 1,704,489 | 1,809,841 |
Total equity | 3,309,444 | 4,307,291 | 5,070,040 |
P&L
| Year | 2024 | 2023 | 2022 |
|---|---|---|---|
Total operating income | 10,960,739 | 10,039,483 | 10,862,203 |
Total operating costs | 9,432,189 | 8,517,463 | 8,840,622 |
Operating result | 1,528,550 | 1,522,019 | 2,021,581 |
Financial income/costs | 81,777 | 67,799 | -6 |
Profit before tax | 1,610,327 | 1,589,818 | 2,021,574 |
Total tax & extraordinary income/cost | 358,173 | 352,568 | 447,880 |
Annual Total Result | 1,252,154 | 1,237,250 | 1,573,694 |
Balance overview
| Year | 2024 | 2023 | 2022 |
|---|---|---|---|
Total fixed assets | 0 | 0 | 0 |
Total current assets | 4,384,947 | 6,011,779 | 6,879,881 |
Total assets | 4,384,947 | 6,011,779 | 6,879,881 |
Short term debt | 1,062,463 | 1,704,489 | 1,809,841 |
Long term debt | 13,040 | 0 | 0 |
Total liabilities | 1,075,503 | 1,704,489 | 1,809,841 |
Contributed capital | 100,000 | 100,000 | 100,000 |
Retained earnings | 3,209,444 | 4,207,291 | 4,970,040 |
Total equity | 3,309,444 | 4,307,291 | 5,070,040 |
Total equity and liabilities | 4,384,947 | 6,011,779 | 6,879,881 |
Classification
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises